Co-Authors
This is a "connection" page, showing publications co-authored by Matthew O'Sullivan and Thomas Snelling.
Connection Strength
0.056
-
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 14; 21(1):646.
Score: 0.056